OK so you thought the title of the other thread was out of date BUT unfortunately there is no way to edit thread titles.

So here is a new title

This one has got the charts at the top again & has a link to the old one.
http://www.moneyam.com/InvestorsRoom/posts.php?tid=5021

I sold half at 21p yesterday morning.

I'm pretty confident that the OXB will have more than 1 winner from its' many drugs.

I don't know when.

Let's hope so apple...

The only people too prosper from OXB are MMs!! Totally agree with queen 1, talk it up one day walk it down the next.
If no news is forth coming then ouch....

Lots of buying going on.

Bought some more.

8% UP so far today.

Hi apple, Sorry been out all afternoon so just seen your request. Now sent so feel free to remove your email addy

Thanks Janus

OXB is likely to go up tomorrow given its chart at the moment

Correct hlyeo98

UP 2.5% so far.

1st resistance @ 21p. If this is breached then next resistance 26-27p. May well test that 21p level later today.

DSTOREY9916 - Perhaps as the pessimists at this party we will be pleasantly surprised. Let's hope so.

queen 1, hope so for sake of those who are suffering with cancer, parkinson's and so on..

Resistance at 21 not breached. May well see a retrenchment early next week but this will only be a breather and expect sp too have an upward trend in anticipation of RNS(s!?). Into a nice higher/low's pattern. However would expect sp too slide if no positive newsflow forth coming in near future given expectations. IMHO.

I agree - have a good weekend and stay lucky.

FINANCIAL TIMES today


Oxford Biomedica
Published: October 9 2004 03:00 | Last updated: October 9 2004 03:00

Shares in Oxford Biomedica rose 21 per cent to 20p after Panmure Gordon initiated coverage of the biotech company with a "buy" recommendation and a target price of 50p. The broker said: "We like Oxford Biomedica because uniquely in the UK biotech sector it has a large number of products at a relatively late stage of R&D. This provides a security net against 'all the eggs in one basket' slip-ups". The company is working on two cancer drugs and several neurotherapy treatments. Panmure expects Oxford Biomedica to sign at least one and up to three partnership deals next year.

Great post Janus. Surely if it signs 3 partnership deals next year 50p will be the very least we could hope for.

UP again so far today.

First obstacle is to get through the 21p barrier - followed by some good news - I am off for a couple of weeks and will be watching daily (from a sun bed with an expensive newspaper)how you all get on in my absence

Enjoy your basting Oakaooles142!